[Expression of VEGF165 and VEGF121 genes in MC3T3-E1 cell line and biological function of their products].
Jun He, Huiming Wang, Hangping Yao
Abstract
Jun He, Huiming Wang, Hangping Yao
Abstract
OBJECTIVE: To construct vectors stably expressing bioactive VEGF165 and VEGF121 in MC3T3-E1 cells. METHODS: VEGF165 and VEGF121 genes were obtained by RT-PCR from HL-60 cells and inserted into eukaryotic expression plasmid pcDNA3.1(+). The constructed plasmids containing right sequence of target genes were transfected into MC3T3-E1 cells by lipofectin. The cells were limitedly diluted twice and selected by G418, the expression of VEGF was tested by ELISA, Western-blot and immunofluorescence essay. The bioactivity of expressed products was proved by MTT method. RESULT: DNA sequencing indicated the sequences of the obtained VEGF165 and VEGF121 were identical to the those reported in Genebank, and the newly-constructed plasmids were VEGF165/pcDNA3.1(+) and VEGF121/pcDNA3.1(+). The results of ELISA, Western-blot and immunofluorescence showed that the transfected cells could express VEGF165 and VEGF121 proteins. And MTT proved the proteins were bioactive. CONCLUSION: The transfected MC3T3-E1 cells could stably express high levels of bioactive VEGF165 and VEGF121.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE: To construct vectors stably expressing bioactive VEGF165 and VEGF121 in MC3T3-E1 cells. METHODS: VEGF165 and VEGF121 genes were obtained by RT-PCR from HL-60 cells and inserted into eukaryotic expression plasmid pcDNA3.1(+). The constructed plasmids containing right sequence of target genes were transfected into MC3T3-E1 cells by lipofectin. The cells were limitedly diluted twice and selected by G418, the expression of VEGF was tested by ELISA, Western-blot and immunofluorescence essay. The bioactivity of expressed products was proved by MTT method. RESULT: DNA sequencing indicated the sequences of the obtained VEGF165 and VEGF121 were identical to the those reported in Genebank, and the newly-constructed plasmids were VEGF165/pcDNA3.1(+) and VEGF121/pcDNA3.1(+). The results of ELISA, Western-blot and immunofluorescence showed that the transfected cells could express VEGF165 and VEGF121 proteins. And MTT proved the proteins were bioactive. CONCLUSION: The transfected MC3T3-E1 cells could stably express high levels of bioactive VEGF165 and VEGF121.
Key concepts: Transfection, Western blot, Plasmid, Molecular biology, Immunofluorescence, Gene, Biology, Cell culture